ADC Therapeutics SA Quick Ratio 2019-2022 | ADCT
Historical quick ratio values for ADC Therapeutics SA (ADCT) over the last 10 years.
ADC Therapeutics SA Quick Ratio Historical Data |
Date |
Current Assets - Inventory |
Current Liabilities |
Quick Ratio |
2022-12-31 |
$0.43B |
$0.10B |
4.32 |
2022-09-30 |
$0.42B |
$0.09B |
4.82 |
2022-06-30 |
$0.41B |
$0.07B |
5.56 |
2022-03-31 |
$0.48B |
$0.07B |
6.72 |
2021-12-31 |
$0.51B |
$0.07B |
6.95 |
2021-09-30 |
$0.56B |
$0.06B |
9.45 |
2021-06-30 |
$0.39B |
$0.05B |
7.51 |
2021-03-31 |
$0.00B |
$0.04B |
0.00 |
2020-12-31 |
$0.00B |
$0.04B |
0.00 |
2020-09-30 |
$0.00B |
$0.03B |
0.00 |
2020-06-30 |
$0.00B |
$0.03B |
0.00 |
2020-03-31 |
$0.00B |
|
0.00 |
2019-12-31 |
$0.00B |
|
0.00 |
2019-09-30 |
$0.00B |
|
0.00 |
2019-06-30 |
$0.00B |
|
0.00 |
2018-12-31 |
$0.00B |
$0.02B |
0.00 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Biomedical and Genetics |
$0.153B |
$0.210B |
ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.
|